Lebrikizumab
Product Specifications
CAS Number
953400-68-5
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.963
Bioactivity
Lebrikizumab is a humanised monoclonal antibody that targets and inhibits interleukin 13 (IL-13), thereby suppressing Th2 inflammation. It is mainly used in the study of asthma and atopic dermatitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
